Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Minority Interest (2022 - 2023)

Zentalis Pharmaceuticals has reported Minority Interest over the past 2 years, most recently at $107000.0 for Q4 2023.

  • Quarterly results put Minority Interest at $107000.0 for Q4 2023, down 51.58% from a year ago — trailing twelve months through Dec 2023 was $107000.0 (down 51.58% YoY), and the annual figure for FY2023 was $107000.0, down 51.58%.
  • Minority Interest for Q4 2023 was $107000.0 at Zentalis Pharmaceuticals, down from $129000.0 in the prior quarter.
  • Over the last five years, Minority Interest for ZNTL hit a ceiling of $368000.0 in Q1 2022 and a floor of $107000.0 in Q4 2023.